Skip to search formSkip to main contentSkip to account menu

SWOG

Known as: Southwest Oncology Group 
An NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956… 
National Institutes of Health

Related topics

Related topics

1 relation
Source of protocol in which patient enrolled:Type:Pt:Cancer.XXX:Nom

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Survival Claims From Observational Data on Cancer Therapy.
2011
2011
S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.
Background: Anastrozole inhibits the aromatase enzyme-induced estrogen synthesis, and fulvestrant down-regulates estrogen… 
Review
2010
Review
2010
Adjuvant Treatment for High-Risk Operable Prostate Cancer
Patients who have undergone a radical prostatectomy may have to face high risks of recurrence. The risk of recurrence is elevated… 
2010
2010
SWOG S0727: A randomized phase II trial of combination gemcitabine plus erlotinib plus IMC-A12 (cixutumumab) versus gemcitabine plus erlotinib as first-line treatment in patients (pts) with…
TPS223 Background: A multitargeted approach in treating pancreatic cancer is rationalized by the multiple genetic abnormalities… 
2008
2008
A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): An NCCTG and SWOG study
8080 Background: This phase II study was performed to evaluate the clinical efficacy and toxicity of pem (500 mg/m2 iv) combined… 
2007
2007
Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III…
7513 Background: Early clinical studies with gefitinib (G) showed promising efficacy and mild toxicity in patients (pts) with… 
2005
2005
Increased EGFR gene copy number detected by fish is associated with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma (BAC) (S0126)
7030 Background: BAC subtypes are increasing in incidence, particularly in younger, never-smoking women. Studies with EGFR… 
2004
2004
Use of computerized tomography (CT) as an early prognostic indicator of response to imatinib mesylate (IM) in patients with gastrointestinal stromal tumors (GIST).
3011 Background: We report results from a pilot study aimed at optimizing the use of CT bi-dimensional measurements (CT-BDM) as a… 
1993
1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
PURPOSE To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide… 
Highly Cited
1977
Highly Cited
1977
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
The Southwest Oncology Group (SWOG) has completed five studies of high-dose intermittent combination chemotherapy for the…